FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Aortic Valve, Prosthesis, Percutaneously Delivered
PMA: P140031
·
Supplement: S145
·
Decision Sep 23, 2022
Classifications
1
FEI Numbers
24
Registration Numbers
24
Basic Information
- Device Name
- Aortic Valve, Prosthesis, Percutaneously Delivered
- Trade Name
- SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (THV) System
- PMA Number
- P140031
- Supplement Number
- S145
- Device Class
- FDA Class 3
- Product Code
- NPT
- Generic Name
- Aortic valve, prosthesis, percutaneously delivered
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- September 23, 2022
- Date Received
- August 25, 2022
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Postapproval Study Protocol
- Expedited Review
- N
Advisory Committee Statement
Approval of the protocol for the post-approval study (PAS) protocol.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NPT | Aortic Valve, Prosthesis, Percutaneously Delivered | FDA class 3 | Unknown |